Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Neogen Corporation (NEOG) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into Neogen’s operations in food safety, animal safety, and related markets, as well as its governance, compensation practices, and financial condition.
Neogen uses current reports on Form 8-K to disclose material events such as the appointment of a new President and Chief Executive Officer, changes in the Chief Financial Officer role, director retirements and appointments, and the results of shareholder votes at its annual meeting. Filings describe executive compensation arrangements, including base salary, annual bonus targets, long-term equity incentives, and performance share unit programs tied to metrics like revenue growth, adjusted EBITDA margin expansion, and cash flow conversion.
Investors can also review 8-K filings that furnish earnings press releases, which summarize quarterly and annual results, segment performance for Food Safety and Animal Safety, and non-GAAP measures such as adjusted EBITDA. These filings complement the company’s financial statements by providing narrative context and reconciliations.
On Stock Titan, NEOG filings are updated as they are posted to EDGAR, and AI-powered summaries can help explain key elements of lengthy documents, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. Users can quickly identify disclosures related to executive and director changes, incentive plans, shareholder meeting outcomes, and other governance matters.
This page is a resource for understanding how Neogen describes its strategy, risk factors, performance metrics, and capital structure in its own words through formal SEC filings, with tools to make complex regulatory content more accessible.
Neogen Corp (NEOG) disclosed a director transaction on a Form 4. On October 27, 2025, 1,777 restricted stock units vested and were settled for an equal number of common shares at a labeled price of $6.19 per share (Transaction Code M).
After the settlement, the director beneficially owned 19,117 shares, held directly. The filing notes that each RSU was the economic equivalent of one share of common stock, and these RSUs vested and were settled for the same number of shares on the stated date.
Neogen Corp (NEOG) insider activity: The company’s Chief Legal Officer reported the vesting and settlement of 9,474 restricted stock units into common stock on 10/27/2025, shown with transaction code M at a stated price of $6.19. A follow-on entry with code F reflects the disposition of 2,085 shares, typically for tax withholding, also at $6.19. After these transactions, the officer directly owned 57,240 shares.
The remarks clarify that each RSU equals one share of common stock and that the RSUs vested on October 27, 2025.
NEOGEN (NEOG) reported an insider transaction by its Chief Financial Officer. On October 27, 2025, 15,504 restricted stock units vested and were settled into the same number of common shares (code M) at $6.19. To cover taxes, 4,261 shares were withheld (code F) at $6.19. After these transactions, the officer directly owned 81,024 shares. Each RSU is equivalent to one share of common stock.
Neogen (NEOG) reported an insider equity event. On October 27, 2025, a former COO had 15,504 restricted stock units vest and convert to common stock (code M at
Each RSU was the economic equivalent of one share of common stock.
Neogen Corp (NEOG) insider filing: An officer (Former CEO) reported RSU vesting and related share movements. On October 27, 2025, 38,759 restricted stock units vested and were settled into an equal number of common shares at $6.19 per share (code M). A separate transaction disposed of 8,527 shares at $6.19 (code F).
Following these transactions, the reporting person beneficially owned 363,081 shares, held directly.
Neogen Corp (NEOG) director reported an RSU vesting on October 27, 2025: 3,553 shares of common stock were acquired via a code “M” conversion at $6.07 per share. Following the settlement, the reporting person beneficially owns 47,913 shares, held directly.
Each RSU equaled one share, and the RSUs vested and were settled for an equal number of shares on October 27, 2025.
Neogen Corporation filed an amended report to update information about a recent board appointment. The company previously disclosed that Avi Pelossof would join its Board of Directors effective
Neogen states that Mr. Pelossof has been appointed to serve on its Audit Committee and its Compensation and Talent Management Committee. The change clarifies his specific committee responsibilities, which were determined after the original report filed on
Neogen Corp (NEOG) reported a routine insider equity event. A director converted restricted stock units into common shares on 10/27/2025 (Transaction Code M). 2,025 shares of common stock were acquired at $6.19 per share upon RSU vesting and settlement. Following the transaction, the director beneficially owns 30,725 shares directly. The filing also lists 4,050 derivative securities (RSUs) beneficially owned after the reported transaction.
Neogen Corp (NEOG) reported an insider equity change by a director. On October 27, 2025, 2,025 restricted stock units vested and were settled into 2,025 shares of common stock (transaction code M) at a listed price of $6.19 per share. Following this settlement, the reporting person directly owned 94,570 shares.
Neogen Corporation (NEOG) reported an insider transaction by a director. On 10/24/2025, the director acquired 19,386 shares of common stock at a $6.19 price and now holds 19,386 shares directly.
The filing also reports a grant of 49,929 stock options with a $6.19 exercise price, expiring on 10/24/2035. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.